Pneumococcal 15-valent conjugate vaccine（PCV15）

Pneumonia is one of the major causes of death in Hong Kong. Pneumococcal infection, particularly infection caused by certain serotypes such as serotype 3, may lead to serious illness and a higher risk of complications.
 
Pneumococcal bacteria can cause a range of conditions, including middle ear infection and pneumonia. In more severe cases, they may lead to invasive pneumococcal disease, such as meningitis, bacteraemia or sepsis, which can be serious and potentially life-threatening.
 
The PCV15 covers 15 pneumococcal serotypes:
 
1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F
 
It provides coverage against pneumococcal serotype 3 and supports protection against invasive pneumococcal disease, including pneumonia, acute otitis media, meningitis and sepsis.
 
The vaccine has been approved for use by the US Food and Drug Administration (FDA) and the European Union.